Supportive Care (Studies)

Patients aged between 2 and 18 years, having a
venous catheter (or blood is drawn for regular
patient care) who are treated with at least 1 of
the 9 drugs of interest.                                                                            PROTECT

Patients aged 3-18 years, treated according
to the medium risk ALL treatment schedule, 
in the second part of maintenance phase
(after cessation of asparaginase), with
clinically relevant dexamethasone induced
neurobehavioral side effects.                                                                   DEXADagen-2


Children between 1 and 19 years of age with
primary ALL, who are treated within or according
to the DCOG ALL-11 or subsequent protocol.                                         TropicALL


Participants (patients and healthy controls), at least
8 years old and able to undergo MRI without general
anesthesia.
(Patients treated according to DCOG ALL-10
or ALL-11, and received ciprofloxacin during treatment).                         MRI Ciproxin